MRSN
Mersana Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MRSN Filings
Filing Date
Form Description
Form Type
2025-12-05
Form SC 14D9 - Solicitation, recommendation statements
2025-12-05 ·
Form SC 14D9 - Solicitation, recommendation statements
2025-12-05
Form SC TO-T - Tender offer statement by Third Party
2025-12-05 ·
Form SC TO-T - Tender offer statement by Third Party
2025-12-04
Form SC TO-C - Written communication relating to an issuer or third party
2025-12-04 ·
Form SC TO-C - Written communication relating to an issuer or third party
2025-11-24
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-24 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SC TO-C - Written communication relating to an issuer or third party
2025-11-14 ·
Form SC TO-C - Written communication relating to an issuer or third party
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form SC14D9C - Written communication relating to third party tender offer
2025-11-14 ·
Form SC14D9C - Written communication relating to third party tender offer
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
2025-11-13
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-13 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
